For patients with lower-risk myelodysplastic syndromes with ring sideroblasts who
allmyfamilycare.com
For patients with lower-risk myelodysplastic syndromes with ring sideroblasts who
(HealthDay)—Transfusion dose density is an independent prognostic factor for progression-free